Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
64.50    -0.30 (-0.46%)
Bid:
64.50
Ask:
65.00
Spread: 0.50 (0.775%)
Market Cap: £100.40m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

Interim Management Statement

10 May 2011 12:00

RNS Number : 2868G
Macfarlane Group PLC
10 May 2011
 



 

INTERIM MANAGEMENT STATEMENT

 

Macfarlane Group PLC today publishes its Interim Management Statement for 2011 to date. At the Annual General Meeting, Archie Hunter, Chairman of Macfarlane Group, said:-

"Revenue in our Packaging Distribution business is 4% ahead of last year and despite continuing raw material price pressure, profitability is well ahead of that achieved in 2010. Progress in this business is now reflecting the impact from a number of our strategic initiatives, most notably increased penetration of the UK third-party logistics sector and the launch of a range of Presentational and Retail Packaging products.

As part of our plan to reduce operating costs in the Packaging Distribution business, the Regional Distribution Centre ("RDC") at Hayes will be relocated in the middle of 2011 to lower cost premises. There are other opportunities under consideration to reduce the long-term property cost of our Packaging Distribution business and these will be advised when concluded.

Our Manufacturing Operations' revenue is 2% below 2010 levels, mainly due to reduced sales volumes in our Labels business, resulting in a small loss in this business for the year to date. However there is good momentum in the Reseal-it™ label range, which we expect to address these pressures and enable the business to return to profitability. Progress continues in the Packaging Manufacturing business, which made a small profit in the year to date.

The Group is evaluating additional strategies to further reduce the pension scheme deficit. Although net debt has increased in line with our normal business cycle in the first half of 2011, the Group continues to operate well within its existing bank facilities. As previously indicated, we shall pay a dividend of 1.05p per share on 9 June 2011, subject to shareholder approval later today.

There are real opportunities for Macfarlane Group in our strategic action plans and these provide encouraging growth potential. We have an able and committed complement of people and they are focused on the exciting challenges ahead. 

Against a background of continuing economic uncertainty, the business continues to perform in line with the Board's expectations for 2011."

 

Further enquiries:

Macfarlane Group

 

Tel: 0141 333 9666

Archie Hunter Chairman

Peter Atkinson Chief Executive

John Love Finance Director

Spreng & Co

Callum Spreng

 

Tel: 07803 970103

 

Notes to Editors:

The 2011 Annual General Meeting of Macfarlane Group PLC will take place on 10 May 2011 at the Thistle Hotel, Cambridge Street, Glasgow.

 

Macfarlane Group PLC is a UK-based group of companies focused on packaging-related activities. The Packaging Distribution business is the leading UK distributor of a comprehensive range of packaging consumable products. The Manufacturing Operations comprise two businesses, the manufacture and supply of transit packaging and the manufacture and supply of self-adhesive and re-sealable labels. Headquartered in Glasgow, Scotland, Macfarlane Group employs 700 people at 22 trading sites, principally in the UK and Ireland, servicing 20,000+ customers, in a wide range of sectors including: fast-moving consumer goods; logistics; electronics; aerospace; automotive; food manufacturing; retail and e-commerce retailing.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUBUAUPGGUU
Date   Source Headline
2nd Oct 20237:00 amRNSAcquisition of B&D 2010 Group Limited
29th Aug 20237:00 amRNSIssue of Shares
24th Aug 20237:00 amRNSHalf-year Report
8th Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
4th Aug 20237:00 amRNSNotice of Results
6th Jul 20231:29 pmRNSHolding(s) in Company
9th May 20233:08 pmRNSResult of AGM
9th May 20237:00 amRNSAGM Trading Update
2nd May 20237:00 amRNSAcquisition
28th Apr 20235:17 pmRNSNotice of AGM
20th Apr 20235:18 pmRNSHolding(s) in Company
20th Apr 20232:03 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSAnnual Report 2022
27th Mar 202312:29 pmRNSDirector/PDMR Shareholding
6th Mar 20237:00 amRNSAcquisition
23rd Feb 20237:00 amRNSAnnual Results 2022
15th Feb 20237:00 amRNSNotice of Results
29th Nov 20227:00 amRNSDirector/PDMR Shareholding
28th Nov 20227:00 amRNSDirector/PDMR Shareholding
24th Nov 20227:00 amRNSTrading Update
7th Oct 202210:00 amRNSHolding(s) in Company
7th Oct 202210:00 amRNSHolding(s) in Company
27th Sep 20221:57 pmRNSHolding(s) in Company
15th Sep 20227:00 amRNSAppointment of Non-Executive Director
8th Sep 20227:00 amRNSDirector/PDMR Shareholding
25th Aug 20227:16 amRNSHalf-year Report
5th Aug 20227:00 amRNSNotice of Results
19th May 20227:00 amRNSDirector/PDMR Shareholding
17th May 202212:00 pmRNSAcquisition
16th May 20227:00 amRNSIssue of Shares
10th May 20223:24 pmRNSResult of AGM
10th May 202212:00 pmRNSTrading Update
6th Apr 20227:00 amRNSNotice of AGM
5th Apr 20227:00 amRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSAnnual Report 2021
25th Mar 20224:12 pmRNSDirector/PDMR Shareholding
11th Mar 20223:41 pmRNSDirector/PDMR Shareholding
24th Feb 20221:00 pmRNSDividend Payment Date
24th Feb 20227:00 amRNSFinal Results
11th Feb 20227:00 amRNSNotice of Results
4th Jan 20227:00 amRNSDisposal
25th Nov 20217:00 amRNSTrading Update
18th Nov 202110:17 amRNSHolding(s) in Company
26th Aug 20217:00 amRNSHalf-year Report
6th Aug 20217:00 amRNSNotice of Interim Results
25th Jun 20214:41 pmRNSSecond Price Monitoring Extn
25th Jun 20214:36 pmRNSPrice Monitoring Extension
12th May 20217:00 amRNSResult of AGM
11th May 202112:00 pmRNSBoard Changes
11th May 202112:00 pmRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.